{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:36:27Z","timestamp":1789050987215,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.micinf.2022.105041","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T12:03:10Z","timestamp":1662033790000},"page":"105041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-7899","authenticated-orcid":false,"given":"Eric","family":"Wombwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.micinf.2022.105041_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases Society of America (IDSA) and Society for healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.micinf.2022.105041_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","article-title":"ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections","volume":"116","author":"Kelly","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.micinf.2022.105041_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2022.105041_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fmed.2018.00124","article-title":"Strain-specificity and disease-specificity of probiotic efficacy: a Systematic review and meta-analysis","volume":"5","author":"McFarland","year":"2018","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.micinf.2022.105041_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209205","article-title":"Choosing an appropriate probiotic product for your patient: an evidence-based practical guide","volume":"13","author":"Sniffen","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.micinf.2022.105041_bib6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-020-06244-z","article-title":"Efficacy of single-strain probiotics versus multi-strain mixtures: Systematic review of strain and disease specificity","volume":"66","author":"McFarland","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.micinf.2022.105041_bib7","article-title":"Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children","volume":"12","author":"Goldenberg","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.micinf.2022.105041_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1017\/ice.2019.236","article-title":"Hospital-level high-risk antibiotic use in relation to hospital-associated Clostridioides difficile infections: retrospective analysis of 2016-2017 data from US hospitals","volume":"40","author":"Tabak","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.micinf.2022.105041_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13756-021-00986-9","article-title":"Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis","volume":"10","author":"Yun","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"10.1016\/j.micinf.2022.105041_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02169-19","article-title":"Antibiotic exposure and risk for hospital-associated Clostridioides difficile infection","volume":"64","author":"Webb","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.micinf.2022.105041_bib11","doi-asserted-by":"crossref","first-page":"e2512","DOI":"10.1093\/cid\/ciaa808","article-title":"The effect of Saccharomyces boulardii primary prevention on risk of hospital-onset Clostridioides difficile infection in hospitalized patients administered antibiotics frequently associated with C. difficile infection","volume":"73","author":"Wombwell","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.micinf.2022.105041_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/myc.13375","article-title":"Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic","volume":"64","author":"Wombwell","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.micinf.2022.105041_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/cid\/cir301","article-title":"Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection","volume":"53","author":"Stevens","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.micinf.2022.105041_bib14","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic Society and infectious diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.micinf.2022.105041_bib15","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases Society of America and the American thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2022.105041_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-015-0925-9","article-title":"Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample","volume":"15","author":"Becerra","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.micinf.2022.105041_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s15010-017-1024-1","article-title":"Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China","volume":"45","author":"Li","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.micinf.2022.105041_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anaerobe.2017.03.004","article-title":"Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids","volume":"45","author":"Thanissery","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.micinf.2022.105041_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2019.00336","article-title":"Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy in healthy volunteers","volume":"10","author":"Kelly","year":"2019","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.micinf.2022.105041_bib20","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/iai.64.12.5225-5232.1996","article-title":"Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum","volume":"64","author":"Castagliuolo","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2022.105041_bib21","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/0016-5085(93)90280-P","article-title":"Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum","volume":"104","author":"Pothoulakis","year":"1993","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.micinf.2022.105041_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01536771","article-title":"Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii","volume":"35","author":"Buts","year":"1990","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.micinf.2022.105041_bib23","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/IAI.69.4.2762-2765.2001","article-title":"Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice","volume":"69","author":"Qamar","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2022.105041_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/CEG.S85574","article-title":"Saccharomyces boulardii CNCM I-745 supports\u00a0regeneration of the intestinal microbiota after diarrheic dysbiosis - a review","volume":"8","author":"Mor\u00e9","year":"2015","journal-title":"Clin Exp Gastroenterol"},{"issue":"1","key":"10.1016\/j.micinf.2022.105041_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.syapm.2015.11.002","article-title":"Functional anatomy of the colonic bioreactor: impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders","volume":"39","author":"Swidsinski","year":"2016","journal-title":"Syst Appl Microbiol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:41:03Z","timestamp":1761144063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457922001113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1286457922001113"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105041","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105041"}}